Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 6Gastrointestinal 4Thoracic 2Other hematologic neoplasm 2NET 2Lymphoid 2Genitourinary 2Endocrine 2Sarcoma 1Other solid neoplasm 1Head & Neck 1Gynecologic 1Dermatologic 1CNS 1Breast 1

Conditions

Financial Stress 1Bone Neoplasms 1

Interventions

Cyclophosphamide 54Specimen Handling 51Magnetic Resonance Spectroscopy 49Doxorubicin 44pembrolizumab 43Radiotherapy 42Temozolomide 38Biopsy 34Radiation 29Nivolumab 28fludarabine 22Vincristine 22Irinotecan 21Gemcitabine 21X-Rays 20Ifosfamide 20Surgical Procedures, Operative 18atezolizumab 17cabozantinib 15Ipilimumab 15Paclitaxel 14olaparib 13Sunitinib 13Etoposide 13Blood Specimen Collection 13regorafenib 12fludarabine phosphate 12Phantoms, Imaging 12Imatinib Mesylate 12Bevacizumab 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Data Collection × Sarcoma × 1 year × Clear all
NCT07215611 2026-04-30

Financial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas

M.D. Anderson Cancer Center

Recruiting
100 enrolled
Sarcoma

Financial Stress, Bone Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡